Effectiveness of COVID-19 vaccination schedules against severe COVID-19 in children aged 6 months to 4 years in Brazil: A population-based cohort study (2023-2024).
In this population-based cohort, completion of the 3-dose BNT162b2 primary series was associated with substantially lower rates of COVID-19-attributed SARI among children aged 6 months to 4 years.